Navigation Links
Endologix Appoints Dan Lemaitre to its Board of Directors
Date:12/10/2009

IRVINE, Calif., Dec. 10 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Dan Lemaitre, former President and CEO of CoreValve, has joined the Endologix Board of Directors effective December 11, 2009. Endologix now has four independent directors and three non-independent directors.

Franklin D. Brown, Chairman of the Board, said, "We are pleased to welcome Dan Lemaitre to the Endologix Board of Directors. He has a proven track record in the medical device industry, with relevant experience in the endovascular sector and the investment community. We expect that Dan will provide valuable advice and strategic contributions as a Board member and I look forward to working with him as we continue to grow Endologix's business."

Mr. Lemaitre most recently served as the President and CEO of CoreValve, a private company focused on percutaneous aortic valve replacement. CoreValve was acquired by Medtronic in April 2009 for $700 million and $150 million of potential milestone payments. Prior to joining CoreValve, Mr. Lemaitre was a Senior Vice President at Medtronic, where he led the company's strategic planning and corporate development. Prior to joining Medtronic, Mr. Lemaitre spent 28 years in the medical device field as an investment analyst. This included 18 years with SG Cowen, where he was a managing director and led the healthcare research team, and six years with Merrill Lynch.

Mr. Lemaitre holds a BA in Economics from Bethany College and an MBA from Bowling Green State University. He is a Chartered Financial Analyst.

The appointment of Mr. Lemaitre also brings the Company back into compliance with Nasdaq's Marketplace Rule 4350(c), which requires the Company to maintain a Board that is comprised of a m
'/>"/>

SOURCE Endologix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 19, 2013 Synthetic Biologics, Inc. (NYSE MKT: SYN), ... of serious infectious diseases, announced today that Jeffrey Riley ... OneMedForum New York Conference on Thursday, June 27, 2013 at ... . Mr. Riley is scheduled to present at 8:40 a.m. ... presentation can be accessed by logging onto the web at ...
(Date:6/19/2013)... Calif. , June 19, 2013 ... plant, stool and other challenging microbial nucleic acid ... Protein Extraction Kit, for extraction of pure protein ... protein world coincides with the 20 th ... growing innovation capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ...
(Date:6/19/2013)...  Continuing its long history of proven clinical performance ... , Inc. announces the U.S. Food and Drug Administration ... I assay for use on its Access 2 immunoassay ... Beckman Coulter,s troponin I test for over 12 ... performance to continue providing dependability to laboratories supporting emergency ...
(Date:6/19/2013)... , June 19, 2013   NineSigma , ... that a year following its launch, NineSights.com ... a focal point for the worldwide community of innovators. ... climate and environmental sustainability experts, NineSights stands out for ... range of scientific and technical disciplines, all vetted by ...
Breaking Biology Technology:Synthetic Biologics to Present at OneMedForum New York 2013 2MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3
... SAN DIEGO, March 3 Bio-Matrix Scientific Group, ... an emerging research and development biotechnology company focused ... at its commercial cryogenic stem cell bank and ... News/Special Report about trends in adult stem cells ...
... Featured on March 9th ... France , and March 17, 2009, at ... ROCKVILLE, Md., March 3 Sequella, Inc., a clinical-stage ... potential has announced that Alan Klein, Sequella Executive Vice President for ...
... emerging Canadian biotech company focused on developing novel ... of target enrollment in its pilot clinical trial ... hypophosphatasia. Enobia is investigating Enzyme Replacement Therapy ... rare and often crippling genetic bone disorder for ...
Cached Biology Technology:Bio-Matrix Scientific Group, Inc. Highlighted in LifeSciencesWorld.com Special Report; Stem Cell Market Projected to Exceed $8 Billion Worldwide by 2016 2Infectious Diseases Company, Sequella, to Present at Upcoming European Conferences 2Enobia Completes Target Enrollment in Clinical Trial for Infantile Hypophosphatasia 2Enobia Completes Target Enrollment in Clinical Trial for Infantile Hypophosphatasia 3
(Date:6/19/2013)... June 19, 2013 AT&T * ... upcoming launch of the ultimate workhorse among ruggedized ... As one of the most ruggedized phones equipped ... Terrain embodies toughened versatility and business-ready features.  Its ... keep workforces moving forward, while also keeping up ...
(Date:6/19/2013)... MedNet Solutions , a global life ... is pleased to announce its participation in the 2013 ... Boston .  This represents the 10 ... cloud-based eClinical solutions, has exhibited at this premier industry ... iMedNet™ EDC , MedNet,s latest, easy-to-use eClinical technology ...
(Date:6/19/2013)... York, NY, June 19, 2013 A decade-long ... Research in Helmholtz Zentrum Mnchen, Germany, is providing ... and the risk of developing type 1 diabetes ... possible preventions for the disease. The study, "Seroconversion ... to Diabetes in Children," was published today in ...
Breaking Biology News(10 mins):AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2New data on islet autoantibodies in young children defines early type 1 diabetes development 2
... breast pathology experts will meet between the 20th and 22nd ... International Society (SIS). This meeting and the 29th Congress of ... take place in the Valencia, coinciding with the International Breast ... of the SIS and the SESPM, "this meeting will allow ...
... be treated like any other animal depending on where the ... the Department of Sociology and Anthropology at Indiana University South ... tend to have a city background. "To think of ... areas," Blouin said, "which makes sense given the utilitarian relationships ...
... Love, exercise and, new research shows, an infrared laser can ... Reserve University and Vanderbilt University found that pulsed light can ... damage to the tissue. The work, "Optical pacing of the ... of Nature Photonics on Aug. 15, 2010. ...
Cached Biology News:1,500 worldwide experts debate the latest advances in breast pathologies' treatments in Valencia 2Dogs' family status depends on family's locale 2A heart beats to a different drummer 2
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... anti-phospho-PTEN (Ser385) ... to amino acid region encompassing ... phospho-PTEN (Ser385), ... Quality Assurance: ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
CCNI Antibody...
Biology Products: